OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001–2019
Martha S. Linet, Rochelle E. Curtis, Sara J. Schonfeld, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102549-102549
Open Access | Times Cited: 6
Martha S. Linet, Rochelle E. Curtis, Sara J. Schonfeld, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102549-102549
Open Access | Times Cited: 6
Showing 6 citing articles:
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
Guadalupe Oñate, Ana Garrido, Montserrat Arnán, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Guadalupe Oñate, Ana Garrido, Montserrat Arnán, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Are we ignoring sex differences in haematological malignancies? A call for improved reporting
Ora Paltiel, Sumita Ratnasingam, Hui‐Peng Lee
British Journal of Haematology (2025)
Open Access
Ora Paltiel, Sumita Ratnasingam, Hui‐Peng Lee
British Journal of Haematology (2025)
Open Access
Superior outcomes of haploidentical hematopoietic cell transplantation over chemotherapy in AML patients 55 years or older
Li Lin, Lixia Zhu, Mengqi Xiong, et al.
Bone Marrow Transplantation (2025)
Closed Access
Li Lin, Lixia Zhu, Mengqi Xiong, et al.
Bone Marrow Transplantation (2025)
Closed Access
The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination
Tao Wang, Junxia Huang, Yongqian Jia, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Tao Wang, Junxia Huang, Yongqian Jia, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Acute myeloid leukemia: does sex matter?
Jesse M. Tettero, Jacqueline Cloos, Lars Bullinger
Leukemia (2024) Vol. 38, Iss. 11, pp. 2329-2331
Open Access | Times Cited: 1
Jesse M. Tettero, Jacqueline Cloos, Lars Bullinger
Leukemia (2024) Vol. 38, Iss. 11, pp. 2329-2331
Open Access | Times Cited: 1
OncoSexome: the landscape of sex-based differences in oncologic diseases
Xinyi Shen, Yintao Zhang, Jiamin Li, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1443-D1459
Open Access | Times Cited: 1
Xinyi Shen, Yintao Zhang, Jiamin Li, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1443-D1459
Open Access | Times Cited: 1
Enhanced venetoclax delivery using L-phenylalanine nanocarriers in acute myeloid leukemia treatment
Liangyu Zhang, Lei Lei, Zhuangzhuang Zhao, et al.
Chinese Chemical Letters (2024), pp. 110316-110316
Closed Access
Liangyu Zhang, Lei Lei, Zhuangzhuang Zhao, et al.
Chinese Chemical Letters (2024), pp. 110316-110316
Closed Access
